Expression of SOCSs in human prostate cancer and their association in prognosis (Q46742441)

24 December 2017

title

Expression of SOCSs in human prostate cancer and their association in prognosis (English)

1 reference

24 December 2017

author

Weide Zhong

13

1 reference

24 December 2017

author name string

Jian-guo Zhu

1

1 reference

24 December 2017

Qi-shan Dai

2

1 reference

24 December 2017

Zhao-dong Han

3

1 reference

24 December 2017

Hui-chan He

4

1 reference

24 December 2017

Ru-jun Mo

5

1 reference

24 December 2017

Guo Chen

6

1 reference

24 December 2017

Yan-fei Chen

7

1 reference

24 December 2017

Yong-ding Wu

8

1 reference

24 December 2017

Sheng-bang Yang

9

1 reference

24 December 2017

Fu-neng Jiang

10

1 reference

24 December 2017

Wei-hong Chen

11

1 reference

24 December 2017

Zhao-lin Sun

12

1 reference

24 December 2017

publication date

11 May 2013

1 reference

24 December 2017

Molecular and Cellular Biochemistry

published in

1 reference

24 December 2017

volume

381

1 reference

24 December 2017

issue

1-2

1 reference

24 December 2017

page(s)

51-59

1 reference

24 December 2017

https://scigraph.springernature.com/pub.10.1007/s11010-013-1687-6

exact match

0 references

cites work

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1687-6

Knocking off the suppressors of cytokine signaling (SOCS): their roles in mammalian pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1687-6

The many faces of the SOCS box.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1687-6

The SOCS box-adapting proteins for ubiquitination and proteasomal degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1687-6

Differential hypermethylation of SOCS genes in ovarian and breast carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1687-6

Methylation of SOCS-3 and SOCS-1 in the carcinogenesis of Barrett's adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1687-6

Tissue-specific mRNA expression profiles of human toll-like receptors and related genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1687-6

Suppressor of cytokine signaling (SOCS)-1 is expressed in human prostate cancer and exerts growth-inhibitory function through down-regulation of cyclins and cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1687-6

Genome-wide expression profiling reveals transcriptomic variation and perturbed gene networks in androgen-dependent and androgen-independent prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1687-6

Higher expression levels of SOCS 1,3,4,7 are associated with earlier tumour stage and better clinical outcome in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1687-6

SOCS6, down-regulated in gastric cancer, inhibits cell proliferation and colony formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1687-6

MicroRNA-23b downregulates peroxiredoxin III in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1687-6

Negative regulation of cytokine signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1687-6

Inflammation in prostate carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1687-6

Suppressor of cytokine signalling-3 is up-regulated by androgen in prostate cancer cell lines and inhibits androgen-mediated proliferation and secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1687-6

Suppressor of cytokine signaling-3 antagonizes cAMP effects on proliferation and apoptosis and is expressed in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1687-6

Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1687-6

Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1687-6

Analysis of the specific pathways and networks of prostate cancer for gene expression profiles in the Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1687-6

Suppressor of cytokine signaling (SOCS) 2, a protein with multiple functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1687-6

Insulin-like growth factor signaling regulates the timing of sensory cell differentiation in the mouse cochlea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1687-6

Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1687-6

STAT5A-mediated SOCS2 expression regulates Jak2 and STAT3 activity following c-Src inhibition in head and neck squamous carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1687-6

Evolution of the androgen receptor pathway during progression of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1687-6

Sox6, jack of all trades: a versatile regulatory protein in vertebrate development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1687-6

Prognostic and predictive relevance of DNAM-1, SOCS6 and CADH-7 genes on chromosome 18q in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1687-6

The nuclear localization of SOCS6 requires the N-terminal region and negatively regulates Stat3 protein levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1687-6

Increased SOCS6 stability with PMA requires its N-terminal region and the Erk pathway via Pkcdelta activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1687-6

Array-comparative genomic hybridization reveals loss of SOCS6 is associated with poor prognosis in primary lung squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1687-6

Methylation of apoptosis related genes in the pathogenesis and prognosis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1687-6

Bilateral orchiectomy with or without flutamide for metastatic prostate cancer

21 January 2018

1 reference

12 December 2020

SOCS-3 antagonizes pro-apoptotic effects of TRAIL and resveratrol in prostate cancer cells

1 reference

12 December 2020

SOCS5 and SOCS6 have similar expression patterns in normal and cancer tissues

1 reference

12 December 2020

Hormone therapy for patients with prostate carcinoma

1 reference

12 December 2020

Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior

1 reference

12 December 2020

10.1007/S11010-013-1687-6

Identifiers

DOI

1 reference

24 December 2017

PubMed ID

23666742

1 reference

24 December 2017